Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Stop the Rheumatoid Arthritis (RA) Cascade Early

Sue Pondrom  |  Issue: May 2008  |  May 1, 2008

Much of the movement towards EACs in the 1990s is credited to work by Dr. Emery early in that decade. He was a founder of the Early Rheumatoid Arthritis Study in 1986, and later the Leeds Early Arthritis Project and Yorkshire Early Arthritis Register. His goal has been the prevention of damage by changing the course of RA. He says the most difficult aspect of that early work was patient recruitment and uncertainty about whether patients would get better in the short term. Happily, their short-term improvement has carried into the long term as well.

The Leeds EAC defines “early” RA patients as those with symptom duration of less than one year, but “ideally three months,” Dr. Emery says. Patients are seen within two weeks of referral.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Challenge: Getting Primary Care Referrals

Because there were initial difficulties in getting the cooperation of local general practitioners to refer early suspected cases of RA, the Leeds EAC team contacted local physicians to re-educate them to the importance of early treatment.

Dr. Emery, along with colleagues from The Netherlands, France, Germany, Austria, and the United States, authored a review article that discussed evidence-based development of a clinical guide for early referral recommendations.4 The article advises rapid referral to a rheumatologist if the patient has three or more swollen joints, metatarsophalangeal/metacar-pophalangeal involvement, and morning stiffness lasting 30 minutes or more.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Austrian rheumatologist contributing to that review was Dr. Smolen, who, along with his associate, Klaus Machold, MD, associate professor in rheumatology at the University of Vienna, started Vienna’s Früharthritis-Ambulanzen EAC in 1996 to provide early treatment and to establish guidelines for fast decision making regarding DMARDs. “This meant we had to reduce the time lag from first telephone contact with the clinic to the actual appointment with the rheumatologists in our clinics,” says Dr. Smolen. “It also meant we needed to reduce the delay in which patients went to a physician because of their joint problems.”

To accomplish this, the doctors devised an information campaign for both physicians and the lay public. “We spoke to representatives of the social security organizations and the president of the chamber of physicians, who liked and supported our initiative,” he says. “We held press conferences for the mass media in order to reach the public. We wrote a series of educational articles on RA and the importance to recognize it early, and these were published in the journal of the chamber of physicians.”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:clinicDiagnosisDiagnostic CriteriaoutcomeRheumatoid Arthritis (RA)Treatment

Related Articles

    Rheumatoid Arthritis: Time Is of the Essence

    June 1, 2008

    Early treatment lessens arthritis pain and disability, but challenges to early detection remain

    European Beacon for Rheumatology

    January 1, 2008

    Josef S. Smolen, MD, led the way for outcomes measures and a scientifically based training program

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    October 11, 2016

    Established wisdom holds that patients with rheumatoid arthritis (RA) will fare better if their disease is diagnosed as early as possible, and treatments with disease-modifying drugs are started before inflammation can do more damage to joints and tissue. Usually, early diagnosis means spotting the clinical signs of disease, but new research tells us more about…

    EULAR 2012: Remission the New Normal for Rheumatoid Arthritis

    August 8, 2012

    Advances in the rheumatology clinic are promising, two experts say.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences